Journals / İstanbul Medical Journal / 2016 / Cilt: 17 - Sayı: 2

Radical Cystectomy and Organ Preservation Treatment Modalities in Muscle- invasive Bladder Cancer

Kasa İnvaze Mesane Tümörlerinde Radikal Sistektomi ve Organ Koruyucu Tedavi Seçenekleri

Pages
41–47
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we aimed to review the treatment modalities for urinary bladder cancer such as radical surgical meth- od and bladder-sparing modalities in light of the current literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Worldwide, bladder carcinoma is the most diagnosed cancer, and it is the most common urologic malignancy among men in Turkey.
📊
Key Findings & Data:Although bladder carcinoma is diagnosed at an early stage of the disease, 100,000 patients are diagnosed with the muscle-invasive or advanced stage each year.
💡
Conclusion & Impact:In this article, we aimed to review the treatment modalities for urinary bladder cancer such as radical surgical meth- od and bladder-sparing modalities in light of the current literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Worldwide, bladder carcinoma is the most diagnosed cancer, and it is the most common urologic malignancy among men in Turkey. Although bladder carcinoma is diagnosed at an early stage of the disease, 100,000 patients are diagnosed with the muscle-invasive or advanced stage each year. Radical cys- tectomy (RC) and bilateral lymph node dissection are the gold standard treat- ments for muscle-invasive bladder cancer. Partial cystectomy, chemotherapy, radiotherapy, transurethral resection, and combined treatment modalities are other treatment options when RC is not suitable for patients. Oncologic outcomes, complications, effects on the quality of life, and cost of treatment change in each treatment modality. In this article, we aimed to review the treatment modalities for urinary bladder cancer such as radical surgical meth- od and bladder-sparing modalities in light of the current literature.

Özet

Mesane kanseri tüm dünyada en sık tanı konulan kanserlerden biri olup Türkiye'de erkeklerde en sık görülen ürolojik kanserdir. Hastaların büyük çoğunluğuna yüzeysel evredeyken tanı konulmakla beraber dünyada her yıl 100.000'den fazla olguya kasa invaze ya da ileri evrede tanı konulabilemektedir. Kasa invaze mesane tümörlerinde en etkin tedavi, günümüzde altın standart olarak kabul edilen radikal sistektomi (RS) ve çift taraflı lenf nodu diseksiyonudur. RS yapılamayan olgular için parsiyel sistektomi, kemoterapi, radyoterapi, maksimal transüretral rezeksiyon ve kombinasyon tedavi seçenekleri vardır. Bu tedavi modaliteleri arasında onkolojik sonuçlar, komplikasyonlar, yaşam kalitesi ve maliyet farkları açısından farklılıklar bulunmaktadır. Bu derlemede amaç, güncel literatür eşliğinde mesane kanseri tedavisinde uygulanan yöntemleri gözden geçirerek radikal cerrahi yöntemle mesane koruyucu girişimlerin değerlendirmesini yapmaktır.

🔖

Cite This Article

YÜCETAŞ, U., KADIHASANOĞLU, M., TOKTAŞ, M. G., KARABAY, E., AYDIN, M. (2022). Radical Cystectomy and Organ Preservation Treatment Modalities in Muscle- invasive Bladder Cancer. İstanbul Medical Journal, Cilt: 17 - Sayı: 2, 41–47. https://ajindex.com/articles/552108

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011
  2. [CrossRef] Hautmann RE, Gschwend JE, de Petriconi RC, Kron M, Volkmer BG. Cystec- tomy for transitional cell carcinoma of the bladder: results of a surgery- only series in the neobladder era. J Urol 2006
  3. [CrossRef] Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 2014
  4. [CrossRef] Chang SS, Hassan JM, Cookson MS, Wells N, Smith JAJ. Delaying radical cystectomy for muscle invasive bladder cancer results in worse patho- logical stage. J Urol 2003
  5. [CrossRef] Huang GJ, Stein JP. Open radical cystectomy with lymphadenectomy remains the treatment of choice for invasive bladder cancer. Curr Opin Urol 2007
  6. [CrossRef] Kim SH, Yu A, Jung JH, Lee YJ, Lee ES. Incidence and risk factors of 30- day early and 90-day late morbidity and mortality of radical cystectomy during a 13-year follow-up: a comparative propensity-score matched analysis of complications between neobladder and ileal conduit. Jpn J Clin Oncol 2014
  7. [CrossRef] Sanchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ, Mal- kowicz SB. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 2003
  8. [CrossRef] Tang K, Xia D, Li H, Guan W, Guo X, Hu Z, et al. Robotic vs. open radical cystectomy in bladder cancer: A systematic review and meta-analysis. Eur J Surg Oncol 2014
  9. [CrossRef] Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Radi- cal cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2013
  10. [CrossRef] Aboumarzouk OM, Hughes O, Narahari K, Drewa T, Chlosta PL, Kynas- ton H. Safety and feasibility of laparoscopic radical cystectomy for the treatment of bladder cancer. J Endourol 2013
  11. [CrossRef] Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. J Urol 2009
  12. [CrossRef] Herr H, Lee C, Chang S, Lerner S. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a colla